Literature DB >> 24735426

Association between vitamin D status and physical function in the severely obese.

T Ahern1, A Khattak, E O'Malley, C Dunlevy, M Kilbane, C Woods, M J McKenna, D O'Shea.   

Abstract

CONTEXT: Mortality is 85% higher in severely obese subjects (body mass index [BMI] > 40 kg/m(2)) than in subjects with a healthy BMI; poor physical function may be contributory. Hypovitaminosis D is common in obese subjects and is associated with physical dysfunction in the elderly.
OBJECTIVE: We determined the relationship between vitamin D status and physical function in severely obese subjects. DESIGN, SETTING, AND PATIENTS: We conducted a clinic-based, cross-sectional study of severely obese subjects. Participants were stratified into three groups according to the Institute of Medicine (IOM) vitamin D status categorization. MAIN OUTCOME MEASURES: We compared levels of self-reported activity and times taken to walk 500 m and to ascend and descend a 17-cm step 50 times.
RESULTS: We recruited 252 subjects (age, 43.7 ± 11.2 y; BMI, 50.7 ± 9.7 kg/m(2)); 25-hydroxyvitamin D (25OHD) concentrations were less than 30 nmol/L in 109 participants. Participants with a 25OHD > 50 nmol/L, compared to those with a 25OHD < 30 nmol/L, had the highest activity levels (3.1 ± 3.4 h/wk versus 1.5 ± 2.5 h/wk; P = .015) and the shortest 500-m walk times (6.2 ± 1.1 min versus 7.4 ± 1.5 min; P = .003). Serum 25OHD concentrations had a weakly positive association with activity level (r = 0.19; P = .008) and a moderately negative association with 500-m walk time (r = -0.343; P < .001).
CONCLUSIONS: Vitamin D status had a significant relationship with physical activity and physical function in this cohort of severely obese subjects. Low activity levels are likely to perpetuate the problem of hypovitaminosis D due to less time spent outdoors. Studies exploring the effects of vitamin D supplementation in this population are warranted.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24735426     DOI: 10.1210/jc.2014-1704

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  A Cross-sectional Examination of Vitamin D, Obesity, and Measures of Pain and Function in Middle-aged and Older Adults With Knee Osteoarthritis.

Authors:  Toni L Glover; Burel R Goodin; Christopher D King; Kimberly T Sibille; Matthew S Herbert; Adriana S Sotolongo; Yenisel Cruz-Almeida; Emily J Bartley; Hailey W Bulls; Ann L Horgas; David T Redden; Joseph L Riley; Roland Staud; Barri J Fessler; Laurence A Bradley; Roger B Fillingim
Journal:  Clin J Pain       Date:  2015-12       Impact factor: 3.442

2.  Serum 25-hydoxyvitamin D concentrations in relation to Hashimoto's thyroiditis: a systematic review, meta-analysis and meta-regression of observational studies.

Authors:  Mario Štefanić; Stana Tokić
Journal:  Eur J Nutr       Date:  2019-05-14       Impact factor: 5.614

3.  The Role of FTO and Vitamin D for the Weight Loss Effect of Roux-en-Y Gastric Bypass Surgery in Obese Patients.

Authors:  Marcus Bandstein; Bernd Schultes; Barbara Ernst; Martin Thurnheer; Helgi B Schiöth; Christian Benedict
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

4.  Associations of Serum 25-Hydroxyvitamin D with Physical Performance and Bone Health in Overweight and Obese Older Adults.

Authors:  Melissa Dang; Cat Shore-Lorenti; Lachlan B McMillan; Jakub Mesinovic; Alan Hayes; Peter R Ebeling; David Scott
Journal:  Int J Environ Res Public Health       Date:  2019-02-12       Impact factor: 3.390

5.  Total vs. Bioavailable: Determining a Better 25(OH)D Index in Association with Bone Density and Muscle Mass in Postmenopausal Women.

Authors:  Nurdiana Z Abidin; Soma R Mitra
Journal:  Metabolites       Date:  2020-12-31

6.  25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 exert distinct effects on human skeletal muscle function and gene expression.

Authors:  Zaki K Hassan-Smith; Carl Jenkinson; David J Smith; Ivan Hernandez; Stuart A Morgan; Nicola J Crabtree; Neil J Gittoes; Brian G Keevil; Paul M Stewart; Martin Hewison
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.